Tag: Michigan

Michigan Accelerator Fund I (MAF-1) has made a $750,000 Series A-1 investment in Swift Biosciences, Inc., the seventh company it has funded.

Start Garden announced they have invested $500,000 in Grand Rapids-based Blue Medora. Grand Angels, a regional group of angel investors, also announced that 20 of their members will also be making investments in Blue Medora which cumulatively equal an additional $750,000, bringing the total amount raised to fund the startup to $1.25 million.

“The MEDC is looking to receive information from companies that have expertise in early stage technology company valuation practices, along with valuation methods utilized, and pricing models for providing those services.”

The growth of venture capital and private equity firms in the state, the financial interest from outside the state and the successful funds being raised are all part of the story Crain’s and MiBiz want to tell in 2013.

The growth of venture capital and private equity firms in the state, the financial interest from outside the state and the successful funds being raised are all part of the story Crain’s and MiBiz want to tell in 2013.

ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.

Michigan-based start-ups have received about $90 million of venture capital investment in 17 different companies.

Renaissance Venture Capital Fund (RVCF) is a venture capital role model for Detroit.

At its June 20, 2012, meeting, the AzulStar board of directors unanimously elected Richard N. Brouwer to be its Chief Executive Officer and Chief Operating Officer.

At its June 20, 2012, meeting, the AzulStar board of directors unanimously elected Richard N. Brouwer to be its Chief Executive Officer and Chief Operating Officer.